ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 85 filers reported holding ALLOVIR INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,274,674 | -38.9% | 1,057,988 | -3.4% | 0.00% | – |
| Q2 2023 | $3,722,058 | -4.1% | 1,094,723 | +11.1% | 0.00% | – |
| Q1 2023 | $3,882,000 | +78546.7% | 985,608 | +2.4% | 0.00% | -100.0% |
| Q4 2022 | $4,936 | -99.9% | 962,050 | +57.9% | 0.00% | 0.0% |
| Q3 2022 | $4,807,000 | +58.8% | 609,131 | -21.5% | 0.00% | – |
| Q2 2022 | $3,027,000 | -41.3% | 775,807 | +1.6% | 0.00% | -100.0% |
| Q1 2022 | $5,157,000 | -33.4% | 763,908 | +27.7% | 0.00% | 0.0% |
| Q4 2021 | $7,741,000 | -58.7% | 598,197 | -20.0% | 0.00% | -50.0% |
| Q3 2021 | $18,733,000 | +17.9% | 747,499 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $15,883,000 | +36.2% | 804,622 | +61.4% | 0.00% | 0.0% |
| Q1 2021 | $11,665,000 | +3662.9% | 498,498 | +6076.4% | 0.00% | – |
| Q4 2020 | $310,000 | +72.2% | 8,071 | +20.8% | 0.00% | – |
| Q3 2020 | $180,000 | – | 6,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |